Column Group Iii, Lp - Net Worth and Insider Trading

Column Group Iii, Lp Net Worth

The estimated net worth of Column Group Iii, Lp is at least $353 Million dollars as of 2024-11-13. Column Group Iii, Lp is the 10% Owner of Revolution Medicines Inc and owns about 5,950,228 shares of Revolution Medicines Inc (RVMD) stock worth over $353 Million. Details can be seen in Column Group Iii, Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Column Group Iii, Lp has not made any transactions after 2020-11-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Column Group Iii, Lp

To

Column Group Iii, Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Column Group Iii, Lp owns 6 companies in total, including NGM Biopharmaceuticals Inc (NGM) , Revolution Medicines Inc (RVMD) , and Constellation Pharmaceuticals Inc (CNST) among others .

Click here to see the complete history of Column Group Iii, Lp’s form 4 insider trades.

Insider Ownership Summary of Column Group Iii, Lp

Ticker Comapny Transaction Date Type of Owner
NGM NGM Biopharmaceuticals Inc 2022-01-24 10 percent owner
RVMD Revolution Medicines Inc 2020-11-16 10 percent owner
CNST Constellation Pharmaceuticals Inc 2020-03-19 10 percent owner
LIMIT LIMIT 2021-08-11 10 percent owner
LIMIT LIMIT 2022-11-21 10 percent owner
LIMIT LIMIT 2021-08-11 10 percent owner

Column Group Iii, Lp Latest Holdings Summary

Column Group Iii, Lp currently owns a total of 1 stock. Column Group Iii, Lp owns 5,950,228 shares of Revolution Medicines Inc (RVMD) as of November 16, 2020, with a value of $353 Million.

Latest Holdings of Column Group Iii, Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RVMD Revolution Medicines Inc 2020-11-16 5,950,228 59.36 353,205,534

Holding Weightings of Column Group Iii, Lp


Column Group Iii, Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Column Group Iii, Lp has made a total of 1 transactions in Revolution Medicines Inc (RVMD) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Revolution Medicines Inc is the sale of 2,027,156 shares on November 16, 2020, which brought Column Group Iii, Lp around $74 Million.

Insider Trading History of Column Group Iii, Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Column Group Iii, Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Column Group Iii, Lp Ownership Network

Ownership Network List of Column Group Iii, Lp

No Data

Ownership Network Relation of Column Group Iii, Lp

Insider Network Chart

Column Group Iii, Lp Owned Company Details

What does NGM Biopharmaceuticals Inc do?

Who are the key executives at NGM Biopharmaceuticals Inc?

Column Group Iii, Lp is the 10 percent owner of NGM Biopharmaceuticals Inc. Other key executives at NGM Biopharmaceuticals Inc include 10 percent owner Column Group L P , director & 10 percent owner David V Goeddel , and Chief Financial Officer Jean-frederic Viret .

NGM Biopharmaceuticals Inc (NGM) Insider Trades Summary

Over the past 18 months, Column Group Iii, Lp made no insider transaction in NGM Biopharmaceuticals Inc (NGM). Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 67,893 shares made by Column Group L P , and a net purchase of 26,811 shares made by David V Goeddel .

In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 94,704 shares were bought by its insiders, resulting in a net purchase of 94,704 shares.

NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NGM Biopharmaceuticals Inc Insider Transactions

No Available Data

Column Group Iii, Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Column Group Iii, Lp. You might contact Column Group Iii, Lp via mailing address: 1700 Owens Street, Suite 500, San Francisco Ca 94158.